448 related articles for article (PubMed ID: 19202520)
1. Coronary artery restenosis: a paradigm of current treatment approaches.
Kiernan TJ; Kiernan GD; Yan BD
Minerva Cardioangiol; 2009 Feb; 57(1):77-94. PubMed ID: 19202520
[TBL] [Abstract][Full Text] [Related]
2. Restenosis related to percutaneous coronary intervention has been solved?
Kivelä A; Hartikainen J
Ann Med; 2006; 38(3):173-87. PubMed ID: 16720432
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological and cellular therapies to prevent restenosis after percutaneous transluminal angioplasty and stenting.
Kiernan TJ; Yan BP; Cruz-Gonzalez I; Cubeddu RJ; Caldera A; Kiernan GD; Gupta V
Cardiovasc Hematol Agents Med Chem; 2008 Apr; 6(2):116-24. PubMed ID: 18473776
[TBL] [Abstract][Full Text] [Related]
4. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
5. Mounting evidence for safety and improved outcomes of drug-eluting stenting: but is it the stent?
King SB; Hannan EL
Circulation; 2008 Oct; 118(18):1783-4. PubMed ID: 18852362
[No Abstract] [Full Text] [Related]
6. Drug-eluting stents: a comprehensive appraisal.
Butt M; Connolly D; Lip GY
Future Cardiol; 2009 Mar; 5(2):141-57. PubMed ID: 19371189
[TBL] [Abstract][Full Text] [Related]
7. Peeling-off labels mounting evidence for benefit of drug-eluting stents with off-label use.
Büttner HJ; Neumann FJ
J Am Coll Cardiol; 2007 Nov; 50(21):2037-8. PubMed ID: 18021869
[No Abstract] [Full Text] [Related]
8. Stenting for small coronary vessels.
Morice MC
J Invasive Cardiol; 2003 Jul; 15(7):377-9. PubMed ID: 12840233
[No Abstract] [Full Text] [Related]
9. Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions.
Kipshidze N; Dangas G; Tsapenko M; Moses J; Leon MB; Kutryk M; Serruys P
J Am Coll Cardiol; 2004 Aug; 44(4):733-9. PubMed ID: 15312851
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous treatment of diseased saphenous vein grafts: current state-of-the-art and future directions.
Vermeersch P; Agostoni P
Minerva Cardioangiol; 2007 Oct; 55(5):637-46. PubMed ID: 17912167
[TBL] [Abstract][Full Text] [Related]
11. Update on drug-eluting stents.
Sims JM
Dimens Crit Care Nurs; 2007; 26(6):237-40. PubMed ID: 18090139
[TBL] [Abstract][Full Text] [Related]
12. Coronary stents: current status.
Garg S; Serruys PW
J Am Coll Cardiol; 2010 Aug; 56(10 Suppl):S1-42. PubMed ID: 20797502
[TBL] [Abstract][Full Text] [Related]
13. Celecoxib and hypertension-insights from the effect of celecoxib on restenosis after coronary angioplasty with a taxus stent trial.
Bangalore S; Khianey S; Messerli FH
Am J Cardiol; 2008 Apr; 101(7):1068. PubMed ID: 18359335
[No Abstract] [Full Text] [Related]
14. The left main facts: faced, spun, but alas too few.
Brinker J
J Am Coll Cardiol; 2008 Mar; 51(9):893-8. PubMed ID: 18308156
[TBL] [Abstract][Full Text] [Related]
15. Applying drug-eluting stents in clinical practice.
King SB
Am J Cardiol; 2007 Sep; 100(5A):25K-31K. PubMed ID: 17719350
[TBL] [Abstract][Full Text] [Related]
16. From randomized trials to routine clinical practice: an evidence-based approach for the use of drug-eluting stents.
Thanigaraj S; Wollmuth JR; Zajarias A; Chemmalakuzhy J; Lasala JM
Coron Artery Dis; 2006 Dec; 17(8):673-9. PubMed ID: 17119375
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous coronary intervention or coronary artery bypass graft for unprotected left main coronary artery disease: the endless debate.
Meliga E; Valgimigli M; Buszman P; Serruys PW
J Am Coll Cardiol; 2008 Aug; 52(7):582-4; author reply 584-6. PubMed ID: 18687257
[No Abstract] [Full Text] [Related]
18. Bifurcation coronary artery disease: current techniques and future directions (part 2).
Rizik DG; Klassen KJ; Hermiller JB
J Invasive Cardiol; 2008 Mar; 20(3):135-41. PubMed ID: 18316830
[No Abstract] [Full Text] [Related]
19. Coronary stenting versus balloon angioplasty in small vessels.
Agostoni P; Biondi-Zoccai GG; Abbate A
J Am Coll Cardiol; 2005 Jan; 45(2):323-4; author reply 324-5. PubMed ID: 15653038
[No Abstract] [Full Text] [Related]
20. Left main coronary artery stenting: crossing the Rubicon.
Alfonso F
J Am Coll Cardiol; 2009 May; 53(19):1769-72. PubMed ID: 19422983
[No Abstract] [Full Text] [Related]
[Next] [New Search]
